Association Between ABCB1 Polymorphism and Stable Warfarin Dose Requirements in Brazilian Patients
The ideal dose of the oral anticoagulant warfarin varies widely among patients, mainly due to genetic factors. Genetic variations that impact warfarin pharmacokinetics and the vitamin K cycle are plausible candidates for being associated with warfarin dose requirements. Therefore, the aim of this st...
Main Authors: | Letícia C. Tavares, Leiliane R. Marcatto, Renata A. G. Soares, Jose E. Krieger, Alexandre C. Pereira, Paulo C. J. L. Santos |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-05-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2018.00542/full |
Similar Items
-
The Effect of CYP2C9 and VKORC1 Genetic Polymorphism on Warfarin Dose Requirements in a Sample of Iraqi Patients
by: Maha Ali Saleh, et al.
Published: (2021-03-01) -
Cohort-specific imputation of gene expression improves prediction of warfarin dose for African Americans
by: Assaf Gottlieb, et al.
Published: (2017-11-01) -
Methylation of CYP1A1 and VKORC1 promoter associated with stable dosage of warfarin in Chinese patients
by: Shiwei He, et al.
Published: (2021-06-01) -
Influence of <i>SH2B3</i>, <i>MTHFD1L</i>, <i>GGCX</i>, and <i>ITGB3</i> Gene Polymorphisms on theVariability on Warfarin Dosage Requirements and Susceptibility to CVD in the Jordanian Population
by: Laith N. AL-Eitan, et al.
Published: (2020-09-01) -
Mekanik Kalp Kapaklı Hastalarda Antikoagülan Kullanımı ve Warfarin Direnci
by: Ergun Salman, et al.
Published: (2015-02-01)